Anti‐interleukin‐4 or ‐13 agents for treating asthma
Gespeichert in:
Veröffentlicht in: | Clinical and experimental allergy 2022-12, Vol.52 (12), p.1361-1364 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1364 |
---|---|
container_issue | 12 |
container_start_page | 1361 |
container_title | Clinical and experimental allergy |
container_volume | 52 |
creator | Boulton, Anne Pacita Rosillo Shen, Yitong |
description | |
doi_str_mv | 10.1111/cea.14242 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2725197488</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2725197488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2782-46431293607719129f411c725250d8681aeb15796856d68faee118a9c451f1003</originalsourceid><addsrcrecordid>eNp1kEtOwzAQhi0EoqWw4AIoEhtYpPX4bXZVVR5SJTawttzUKSlpUuxEqDuOwBk5CYYUFkjMZsaeT59GP0KngIcQa5Q5OwRGGNlDfaCCpyTWPupjzVkqlWY9dBTCCmNMuVaHqEcFITou--hqXDXFx9t7UTXOl659Lqr4Ykntk9iBJnbpqiYkefxovLNNUS0TG5qntT1GB7ktgzvZ9QF6vJ4-TG7T2f3N3WQ8SzMiFUmZYBSIpgJLCTpOOQPIJOGE44USCqybA5daKC4WQuXWOQBldcY45BBPHqCLzrvx9UvrQmPWRchcWdrK1W0wJLpAS6ZURM__oKu69VW8LlKcMiCSkkhddlTm6xC8y83GF2vrtwaw-QrUxEDNd6CRPdsZ2_naLX7JnwQjMOqA16J02_9NZjIdd8pPGlR9Pw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2753412732</pqid></control><display><type>article</type><title>Anti‐interleukin‐4 or ‐13 agents for treating asthma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Boulton, Anne Pacita Rosillo ; Shen, Yitong</creator><creatorcontrib>Boulton, Anne Pacita Rosillo ; Shen, Yitong</creatorcontrib><identifier>ISSN: 0954-7894</identifier><identifier>EISSN: 1365-2222</identifier><identifier>DOI: 10.1111/cea.14242</identifier><identifier>PMID: 36229954</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Anti-Asthmatic Agents - therapeutic use ; Asthma ; Humans</subject><ispartof>Clinical and experimental allergy, 2022-12, Vol.52 (12), p.1361-1364</ispartof><rights>2022 John Wiley & Sons Ltd.</rights><rights>Copyright © 2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2782-46431293607719129f411c725250d8681aeb15796856d68faee118a9c451f1003</cites><orcidid>0000-0002-7966-922X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fcea.14242$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fcea.14242$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36229954$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boulton, Anne Pacita Rosillo</creatorcontrib><creatorcontrib>Shen, Yitong</creatorcontrib><title>Anti‐interleukin‐4 or ‐13 agents for treating asthma</title><title>Clinical and experimental allergy</title><addtitle>Clin Exp Allergy</addtitle><subject>Anti-Asthmatic Agents - therapeutic use</subject><subject>Asthma</subject><subject>Humans</subject><issn>0954-7894</issn><issn>1365-2222</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtOwzAQhi0EoqWw4AIoEhtYpPX4bXZVVR5SJTawttzUKSlpUuxEqDuOwBk5CYYUFkjMZsaeT59GP0KngIcQa5Q5OwRGGNlDfaCCpyTWPupjzVkqlWY9dBTCCmNMuVaHqEcFITou--hqXDXFx9t7UTXOl659Lqr4Ykntk9iBJnbpqiYkefxovLNNUS0TG5qntT1GB7ktgzvZ9QF6vJ4-TG7T2f3N3WQ8SzMiFUmZYBSIpgJLCTpOOQPIJOGE44USCqybA5daKC4WQuXWOQBldcY45BBPHqCLzrvx9UvrQmPWRchcWdrK1W0wJLpAS6ZURM__oKu69VW8LlKcMiCSkkhddlTm6xC8y83GF2vrtwaw-QrUxEDNd6CRPdsZ2_naLX7JnwQjMOqA16J02_9NZjIdd8pPGlR9Pw</recordid><startdate>202212</startdate><enddate>202212</enddate><creator>Boulton, Anne Pacita Rosillo</creator><creator>Shen, Yitong</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7966-922X</orcidid></search><sort><creationdate>202212</creationdate><title>Anti‐interleukin‐4 or ‐13 agents for treating asthma</title><author>Boulton, Anne Pacita Rosillo ; Shen, Yitong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2782-46431293607719129f411c725250d8681aeb15796856d68faee118a9c451f1003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Anti-Asthmatic Agents - therapeutic use</topic><topic>Asthma</topic><topic>Humans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boulton, Anne Pacita Rosillo</creatorcontrib><creatorcontrib>Shen, Yitong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental allergy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boulton, Anne Pacita Rosillo</au><au>Shen, Yitong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anti‐interleukin‐4 or ‐13 agents for treating asthma</atitle><jtitle>Clinical and experimental allergy</jtitle><addtitle>Clin Exp Allergy</addtitle><date>2022-12</date><risdate>2022</risdate><volume>52</volume><issue>12</issue><spage>1361</spage><epage>1364</epage><pages>1361-1364</pages><issn>0954-7894</issn><eissn>1365-2222</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>36229954</pmid><doi>10.1111/cea.14242</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0002-7966-922X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0954-7894 |
ispartof | Clinical and experimental allergy, 2022-12, Vol.52 (12), p.1361-1364 |
issn | 0954-7894 1365-2222 |
language | eng |
recordid | cdi_proquest_miscellaneous_2725197488 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Anti-Asthmatic Agents - therapeutic use Asthma Humans |
title | Anti‐interleukin‐4 or ‐13 agents for treating asthma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T02%3A22%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anti%E2%80%90interleukin%E2%80%904%20or%20%E2%80%9013%20agents%20for%20treating%20asthma&rft.jtitle=Clinical%20and%20experimental%20allergy&rft.au=Boulton,%20Anne%20Pacita%20Rosillo&rft.date=2022-12&rft.volume=52&rft.issue=12&rft.spage=1361&rft.epage=1364&rft.pages=1361-1364&rft.issn=0954-7894&rft.eissn=1365-2222&rft_id=info:doi/10.1111/cea.14242&rft_dat=%3Cproquest_cross%3E2725197488%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2753412732&rft_id=info:pmid/36229954&rfr_iscdi=true |